LU84306A1 - Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazoline-2(3h)-one et un agent anti-inflammatoire - Google Patents

Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazoline-2(3h)-one et un agent anti-inflammatoire Download PDF

Info

Publication number
LU84306A1
LU84306A1 LU84306A LU84306A LU84306A1 LU 84306 A1 LU84306 A1 LU 84306A1 LU 84306 A LU84306 A LU 84306A LU 84306 A LU84306 A LU 84306A LU 84306 A1 LU84306 A1 LU 84306A1
Authority
LU
Luxembourg
Prior art keywords
anagrelide
aggregation
amount
pharmaceutical composition
acetylsalicylic acid
Prior art date
Application number
LU84306A
Other languages
English (en)
French (fr)
Inventor
James Stuart Fleming Jr
Joseph Paul Buyniski
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU84306A1 publication Critical patent/LU84306A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU84306A 1981-07-30 1982-07-29 Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazoline-2(3h)-one et un agent anti-inflammatoire LU84306A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/288,639 US4357330A (en) 1981-07-30 1981-07-30 Pharmaceutical compositions
US28863981 1981-07-30

Publications (1)

Publication Number Publication Date
LU84306A1 true LU84306A1 (fr) 1983-04-13

Family

ID=23107996

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84306A LU84306A1 (fr) 1981-07-30 1982-07-29 Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazoline-2(3h)-one et un agent anti-inflammatoire

Country Status (12)

Country Link
US (1) US4357330A (ja)
JP (1) JPS5826817A (ja)
AU (1) AU559161B2 (ja)
BE (1) BE893974A (ja)
CA (1) CA1181010A (ja)
DE (1) DE3228402A1 (ja)
FR (1) FR2510406B1 (ja)
GB (1) GB2103090B (ja)
IE (1) IE54277B1 (ja)
LU (1) LU84306A1 (ja)
MY (1) MY8800110A (ja)
ZA (1) ZA825397B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524051A1 (de) * 1985-07-05 1987-01-15 Hoechst Ag Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
CA2171073A1 (en) * 1995-12-04 1997-06-05 Philip C. Lang Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine
CA2382547A1 (en) * 1999-09-21 2001-03-29 Stephen R. Hanson Methods and compositions for treating platelet-related disosders
US6194420B1 (en) 1999-11-30 2001-02-27 Roberts Laboratories Inc. 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
US6388073B1 (en) * 2000-07-26 2002-05-14 Shire Us Inc. Method for the manufacture of anagrelide
WO2004064841A1 (en) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation and methods for the treatment of thrombocythemia
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US8304420B2 (en) * 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
CN101463035A (zh) * 2007-12-19 2009-06-24 华生制药私人有限公司 生产盐酸阿那格雷一水合物的改进方法
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
GB201017783D0 (en) 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
US4124715A (en) 1977-05-16 1978-11-07 Jose Pozuelo Method of pharmacologically treating drug addiction with fusaric acid

Also Published As

Publication number Publication date
US4357330A (en) 1982-11-02
JPH0237328B2 (ja) 1990-08-23
JPS5826817A (ja) 1983-02-17
GB2103090A (en) 1983-02-16
IE54277B1 (en) 1989-08-16
AU559161B2 (en) 1987-02-26
DE3228402A1 (de) 1983-02-24
FR2510406A1 (fr) 1983-02-04
DE3228402C2 (ja) 1992-01-23
MY8800110A (en) 1988-12-31
GB2103090B (en) 1985-07-17
BE893974A (fr) 1983-01-31
ZA825397B (en) 1983-06-29
AU8652782A (en) 1983-02-03
CA1181010A (en) 1985-01-15
IE821828L (en) 1983-01-30
FR2510406B1 (fr) 1986-05-09

Similar Documents

Publication Publication Date Title
LU84306A1 (fr) Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazoline-2(3h)-one et un agent anti-inflammatoire
RU2261093C2 (ru) Производное пирролидинацетамида или его комбинация для лечения расстройств цнс
EP1536782B1 (en) Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain
KR20080089512A (ko) 근골격계 질환 및 이와 관련된 증상을 치료하기 위한 방법,조성물 및 키트
WO2005105113A2 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
WO1999026657A1 (en) Inhibitors of nitric oxide synthase
HU226165B1 (en) Analgesic compositions comprising anti-epileptic compounds and non-steroid anti-inflammatory dr4gs
JPH0729918B2 (ja) 慢性の対宿主移植片疾患治療剤
JPH11507669A (ja) シクロオキシゲナーゼ−２インヒビターとロイコトリエンｂ▲下４▼受容体アンタゴニストの組合せによる炎症と炎症関連疾患の治療
CA2261099C (fr) Composition pharmaceutique antithrombotique et antiatherogene comprenant un derive de thienopyridine et un inhibiteur de la hmg-coa-reductase
EP0336851A1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
WO1998056365A1 (fr) INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE
US20090239926A1 (en) Methods for the treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-carboxamide
WO1993017680A1 (en) Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
FR2590170A1 (fr) Agents therapeutiques a base de sel d'acyloxyalcanoylcholine, apportant une amelioration dans le traitement de la demence
US4444777A (en) Pharmaceutical compositions of anagrelide and sulfinpyrazone
JP2008534526A (ja) 湿疹の治療のためのオキサプロジンまたは密接に関連する化合物
ES2383005T3 (es) Medicamentos para enfermedades glomerulares
JPH03151329A (ja) 冠状血管内皮の血管弛緩作用回復および冠状血管痙攣防止用剤
PT1673091E (pt) Combinação compreendendo candesartan e rosuvastatina para o tratamento de aterosclerose
US4534975A (en) Pharmaceutical composition containing 24,25-dihydroxycholecalciferol in methods of treatment
FR2690847A1 (fr) Compositions à activité agoniste des récepteurs analogues à 5HT1 sélective.
FR2548900A1 (fr) Compositions pharmaceutiques synergiques
KR0133555B1 (ko) 5-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암조성물
JPS6056920A (ja) 脂質レベルの低減方法